Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
about
Clinically Available Medicines Demonstrating Anti-Toxoplasma ActivityIn vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondiiIn vitro and in vivo effects of doxycycline on Toxoplasma gondiiRemarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondiiIn vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondiiAzithromycin, a macrolide antibiotic with potent activity against Toxoplasma gondiiLocalization of azithromycin in Toxoplasma gondii-infected cellsIn vitro effects of three new 1,2,4-trioxanes (pentatroxane, thiahexatroxane, and hexatroxanone) on Toxoplasma gondii.Effect of roxithromycin on acute toxoplasmosis in miceComparative activity of macrolides against Toxoplasma gondii demonstrating utility of an in vitro microassay.New directions for macrolide antibiotics: structural modifications and in vitro activity.Recent developments in the prevention and treatment of congenital toxoplasmosis.Current problems in the management of AIDS patients.Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes.Opportunistic/nosocomial infections. Treatment and developmental therapeutics. Toxoplasmosis.Effect of Nigella sativa oil on experimental toxoplasmosis.The potential role of azithromycin in the treatment of prophylaxis of toxoplasmosis.Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient.In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.Assessment of spiramycin-loaded chitosan nanoparticles treatment on acute and chronic toxoplasmosis in mice.
P2860
Q26782581-A6CE22BD-6E0D-4319-A87E-599BD7A53B50Q28321674-55D59D0D-1597-4B95-9746-608ED59F38D2Q28335472-234D812C-1D0C-401A-8773-5C14E26B2A86Q28335576-97219692-E91C-47DC-8C3A-1AF883DF55CCQ28359823-858BA1F7-2B7D-4454-A454-245EAFED1AA9Q28359844-6084D1FA-055E-4577-AE0E-58F717611CE7Q33755229-FDF60FE5-6CD1-486B-999F-9737903473B7Q35354962-06289CF1-C2F2-4F9F-83B1-01D58C8E194FQ35540929-BE37C403-807E-4E08-9175-B8F225F0D046Q36753766-09E1F5CB-31C5-4E02-B96E-6CE8ABFDE482Q38721368-C657BFF6-6B68-4D72-BEFD-2308178A78DFQ38774985-AE47DA2A-C1F6-4F36-8BFF-CA9EB9EC1E69Q39217909-4DA3F14C-0429-4FFD-ABF0-31EEAA5285D9Q39828887-8CC8A8DC-4EC7-4F6A-8268-10CD993D528DQ40865388-3AC812A3-6D3B-41DD-A8DB-90CC519EB088Q40962264-2D2E18C0-77DE-4168-BFD7-86F0735C5162Q41000192-ADF4FEE0-E41C-441A-A0DF-D8911C089DF5Q45076759-301EDBAC-4E05-4750-97E3-75AA57D759D6Q48222467-23637781-2300-4092-AD1F-F22F5D9195E1Q53701649-45F5BA5E-AFA3-4E62-9924-BF99B8476BBB
P2860
Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@ast
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@en
type
label
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@ast
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@en
prefLabel
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@ast
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@en
P2860
P356
P1476
Activity of roxithromycin (RU ...... asma gondii infection in mice.
@en
P2860
P304
P356
10.1128/AAC.30.2.323
P407
P577
1986-08-01T00:00:00Z